Embargo period definition
Embargo period. The period of time during which free access to the full text of an article is delayed.
Embargo period means the period commencing on the date substantial highway authority works are completed and ending immediately after the expiry of such length of time as the States may by Regulations specify;
Embargo period means the period beginning on the Effective Date and continuing until and ending on the five (5) year anniversary of the Effective Date.
Examples of Embargo period in a sentence
Temporary restoration of the streets and sidewalks and removal thereof, if required for the Holiday Embargo period, will be paid for under the appropriate scheduled items.
If the Work is subject to an Embargo, Depositary, to the best of its ability and means, shall provide effective (technical) facilities to prevent unauthorised third parties from calling up and/or reusing the Work, or parts of the Work, during the Embargo period.
More Definitions of Embargo period
Embargo period means a period of time, to be specified in a project plan, which extends for no more than five years after the end of the scanning phase for the Digital Materials covered by a Project Plan or segmented portion of a series of Digital Materials in a Project Plan, within which all Digital Materials for that series or segmented portion created by Moon Collectors, LLC will be published exclusively by Moon Collectors, LLC.
Embargo period means the period that starts on the date of submission of the User Access Report and during which the Treated Data, Documentation Data or Simplified Data shall not be released to the public. The Embargo Period in principle lasts 18 months but may be extended or shortened in accordance with the provisions of this Annex;
Embargo period means the period during which PACT-Funded CIMAC Data and PACT Results generated from a clinical trial supported by PACT Funds will be held in confidence for use only by the Clinical Trial Team, all CIMAC-CIDC investigators, and PACT Collaborator(s). All PACT-Funded CIMAC Data and PACT Results must be made available in the controlled-access CIDC for sharing with requestors from the general research community simultaneously with publication in manuscript form of the primary Supplementary Biomarker Analysis for the trial or within 6 months after the primary outcome of the trial is published in manuscript form or the results are posted on ClinicalTrials.gov, whichever occurs first. If the primary Supplementary Biomarker Analysis for the trial is included in the primary outcome manuscript, then the data must be made available for broad use within the CIDC simultaneously with that publication. The Embargo Period may be extended on PACT Collaborator request to PACT JSC.
Embargo period. The period of five years, which begins on the first of January after the end of the scanning phase for the Digital Images covered by a Project Plan or segmented portion of a series of Digital Materials in a Project Plan, within which all Digital Materials for that series or segmented portion created by Ancestry will be published exclusively by Ancestry.
Embargo period means the period identified in Schedule A during which the Dataset or a part thereof shall have been deposited with the Evidence Centre but shall not be made available to third party users;
Embargo period means a period of time, to be specified in a project plan, which extends for no more than five (5) years after the end of the scanning phase for the Digital Images covered by the Project Plan or segmented portion of a series of Digital Materials in a Project Plan, within which all Digital Materials for that series or segmented portion created by DAR will be published exclusively by DAR.
Embargo period means the period during which data generated from a clinical trial supported in whole or in part by NCI will be held in confidence for use only by the Clinical Trial Team, Correlative Study Analysis Team, CIMAC-CIDC Principal Investigators, and any relevant NCI/Pharma Collaborators. The Embargo Period will be in effect until six (6) months after the primary outcome of the trial is either published in manuscript form or, if there is no publication, six (6) months after the results are posted to ▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇. The Embargo Period may be extended on NCI/Pharma Collaborator request to NCI.